121 related articles for article (PubMed ID: 38554304)
1. Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients.
Dogan I; Paksoy N; Basaran M
J Cancer Res Ther; 2024 Jan; 20(1):93-97. PubMed ID: 38554304
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.
Bupathi M; Hays JL; Chen JL
PLoS One; 2017; 12(11):e0188116. PubMed ID: 29141017
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.
Dogan I; Iribas A; Ahmed MA; Basaran M
J Chemother; 2023 Jul; 35(4):343-347. PubMed ID: 35894948
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series.
Yoo KH; Kim HS; Lee SJ; Park SH; Kim SJ; Kim SH; La Choi Y; Shin KH; Cho YJ; Lee J; Rha SY
BMC Cancer; 2015 Mar; 15():154. PubMed ID: 25885855
[TBL] [Abstract][Full Text] [Related]
5. Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study.
Kim HJ; Kim Y; Lee SJ; Lee J; Park SH
J Gynecol Oncol; 2018 Jan; 29(1):e3. PubMed ID: 29185261
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.
Yovine A; Riofrio M; Blay JY; Brain E; Alexandre J; Kahatt C; Taamma A; Jimeno J; Martin C; Salhi Y; Cvitkovic E; Misset JL
J Clin Oncol; 2004 Mar; 22(5):890-9. PubMed ID: 14990645
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
[TBL] [Abstract][Full Text] [Related]
8. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
[TBL] [Abstract][Full Text] [Related]
9. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
10. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
11. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
Menegaz BA; Cuglievan B; Benson J; Camacho P; Lamhamedi-Cherradi SE; Leung CH; Warneke CL; Huh W; Subbiah V; Benjamin RS; Patel S; Daw N; Hayes-Jordan A; Ludwig JA
Oncologist; 2018 Mar; 23(3):360-366. PubMed ID: 29212731
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Garcia del Muro X; Lopez-Pousa A; Martin J; Buesa JM; Martinez-Trufero J; Casado A; Poveda A; Cruz J; Bover I; Maurel J;
Cancer; 2005 Oct; 104(8):1706-12. PubMed ID: 16134177
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy.
Hirbe AC; Eulo V; Moon CI; Luo J; Myles S; Seetharam M; Toeniskoetter J; Kershner T; Haarberg S; Agulnik M; Monga V; Milhem M; Parkes A; Robinson S; Okuno S; Attia S; Van Tine BA
Eur J Cancer; 2020 Sep; 137():1-9. PubMed ID: 32712457
[TBL] [Abstract][Full Text] [Related]
14. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Bilici A; Koca S; Karaagac M; Aydin SG; Eraslan E; Kaplan MA; Ocak B; Goksu SS; Paydas S; Akgul F; Derin S; Ergun Y; Yekeduz E; Erol C; Ozyukseler DT; Demiray AG; Karaca M; Guc ZG; Menekse S; Cinkir HY; Gumusay O; Sakin A; Ozkul O; Demir H; Erdem D; Besiroglu M; Unal OU; Acar R; Koral L; Sahin S; Sakalar T; Bahceci A; Ozveren A; Gunaydin UM; Seker MM; Sunar V; Dal P; Artac M; Turhal S
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8243-8253. PubMed ID: 37067546
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting prognosis and treatment strategies in metastatic soft tissue sarcomas: twenty years of experience.
İlhan A; Eraslan E; Yildiz F; Arslan ÜY; Alkiş N
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6465-6472. PubMed ID: 34787850
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
[TBL] [Abstract][Full Text] [Related]
17. Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma.
Noujaim J; Constantinidou A; Messiou C; Thway K; Miah A; Benson C; Judson I; Jones RL
Am J Clin Oncol; 2018 Feb; 41(2):147-151. PubMed ID: 26523439
[TBL] [Abstract][Full Text] [Related]
18. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Siena S; Crinò L; Danova M; Del Prete S; Cascinu S; Salvagni S; Schiavetto I; Vitali M; Bajetta E
Ann Oncol; 2010 Mar; 21(3):655-661. PubMed ID: 19767314
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of CT-guided
Chen Y; Jiang Y; Ji Z; Jiang P; Xu F; Zhang Y; Guo F; Peng R; Li X; Sun H; Lei R; Fan J; Li W; Wang J
Brachytherapy; 2020; 19(1):81-89. PubMed ID: 31653566
[TBL] [Abstract][Full Text] [Related]
20. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
van der Graaf WT; Blay JY; Chawla SP; Kim DW; Bui-Nguyen B; Casali PG; Schöffski P; Aglietta M; Staddon AP; Beppu Y; Le Cesne A; Gelderblom H; Judson IR; Araki N; Ouali M; Marreaud S; Hodge R; Dewji MR; Coens C; Demetri GD; Fletcher CD; Dei Tos AP; Hohenberger P; ;
Lancet; 2012 May; 379(9829):1879-86. PubMed ID: 22595799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
